CALB1 and Alzheimer disease: For example, 5-HT6 antagonists appear to improve cognition in mild to moderate Alzheimer’s disease [120, 121] which interestingly, and consistent with our working hypothesis, does not appear to involve calbindin deficits in CA1 [122–124].